De Novo Posttransplant Thrombotic Microangiopathy Localized Only to the Graft in APKD with Thrombophilia
نویسندگان
چکیده
Background: Thrombotic microangiopathy (TMA) is a serious complication of renal transplantation (Tx) and is mostly related to the prothrombotic effect of calcineurin inhibitors (CNIs). A subset of TMA (29-38%) is localized only to the graft. Case 1: A young woman suffering from adult polycistyc kidney disease (APKD) underwent kidney transplant. After 2 months, she showed slow renal deterioration (Scr from 1.9 to 3.1 mg/dl), without hematological signs (anaemia, low platelets, low serum haptoglobins, schistocytosis >1%) of haemolytic-uremic syndrome (HUS); only lactate dehydrogenase enzyme (LDH) transient increase was detected. Renal biopsy showed TMA: temporary withdraw of tacrolimus and plasmapheresis was performed. The renal function recovered and stabilized (Scr 1.9 mg/dL). From Screening for thrombophilia, we found a mutation of the Leiden Factor V gene. Case 2: An old man affected by APKD underwent Tx, with delayed graft function (DGF); first biopsy showed acute tubular necrosis, but a second biopsy on day 45 revealed TMA; no altered hematological parameters of HUS was detected. Again, we observed only a light increase of LDH levels. The tacrolimus was halved and plasmapheresis was performed: LDH levels normalized within 10 days and renal function improved (Scr from 9 to 2.9 mg/dl). In this patient, we found a mutation of the Prothrombin gene. Only a renal biopsy clarifies the diagnosis of TMA localized into the graft, but it is necessary to pay attention to light increasing level of LDH. Conclusions: Prothrombotic effect of CNIs and M-Thor inhibitor, mutation of genes encoding factor H or I, anticardiolipin antibodies, vascular rejection, cytomegalovirus or parvovirus B19 infection are proposed to trigger TMA; we detected mutations of Factor II and Leiden Factor V, as facilitating conditions for TMA in patients affected by APKD. Citation: Rolla D, Fontana I,Ravetti JL, Marsano L, Bellino D, et al. (2015) De Novo Posttransplant Thrombotic Microangiopathy Localized Only to the Graft in APKD with Thrombophilia. J Kidney 1: 101. doi:10.4172/2472-1220.1000101
منابع مشابه
De novo Thrombotic Microangiopathy Induced by Cytomegalovirus Infection Leading to Renal Allograft Loss
After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been...
متن کاملDe novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been...
متن کاملDe novo post-transplant thrombotic microangiopathy localized only to the graft in autosomal dominant polycystic kidney disease with thrombophilia
INTRODUCTION Thrombotic microangiopathy (TMA) is a serious complication of renal transplantation and is mostly related to the prothrombotic effect of calcineurin inhibitors (CNIs). A subset of TMA (29%-38%) is localized only to the graft. Case 1: A young woman suffering from autosomal dominant polycystic kidney disease (ADPKD) underwent kidney transplant. After 2 months, she showed slow renal d...
متن کاملThrombotic microangiopathy after kidney transplantation.
Thrombotic microangiopathy (TMA) is a severe complication of kidney transplantation that often causes graft failure. TMA may occur de novo, often triggered by immunosuppressive drugs and acute antibody-mediated rejection, or recur in patients with previous history of hemolytic uremic syndrome (HUS). Recurrent TMA is very rare in patients who had developed end-stage renal failure following HUS c...
متن کاملIdiopathic Pneumonia Syndrome and Thrombotic Microangiopathy Following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation and Posttransplant Cyclophosphamide
Posttransplant high-dose cyclophosphamide (pT-HDCy) following T-cell-replete haploidentical bone marrow (BM) transplantation has been successfully utilized to control alloreactivity, mainly in ameliorating graft-versus-host disease (GVHD) and graft rejection. Recently, peripheral blood stem cells (PBSCs) have also been suggested to be a feasible and effective graft alternative to BM in the same...
متن کامل